ArticleFEBS open bio2021
Preclinical efficacy and toxicity studies of a highly specific chimeric anti-CD47 antibody.
Zhiqiang Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it
ArticleFEBS open bio2021
Zhiqiang Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.